HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Thirunavukkarasu, M. Articles by Maulik, N. Search for Related Content PubMed PubMed Citation Articles by Thirunavukkarasu, M. Articles by Maulik, N.

Niacin-bound chromium enhances myocardial protection from ischemia-reperfusion injury

¹Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut Medical Center, Farmington, Connecticut; ²InterHealth Research Center, Benicia, California; and ³Department of Pharmacy Sciences, Creighton University Medical Center, Omaha, Nebraska

Submitted 4 February 2006 ; accepted in final form 21 March 2006

A novel niacin-bound, chromium-based energy formula (EF; InterHealth Nutraceuticals, Benicia, CA) has been developed in conjunction with D-ribose, caffeine, ashwagandha extract (containing 5% withanolides), and selected amino acids. We have assessed the efficacy of oral administration of EF (40 mg·kg body wt^–1·day^–1) in male and female rats over a period of 90 consecutive days on the cardiovascular and pathophysiological functions in an isolated rat heart model. After 30, 60, and 90 days of treatment with EF, the hearts of male and female rats were subjected to 30 min of global ischemia followed by 2 h of reperfusion and were measured for myocardial ATP, creatine phosphate (CP), phosphorylated AMP kinase (p-AMPK), and heat shock proteins. Myocardial ATP and CP levels were increased in both male and female rats after EF treatment compared with the controls. Western blot analyses were performed to quantify the expression of stress-related proteins such as heat shock proteins (HSP-70, -32, and -25) and are found to be increased in both male and female rats after EF treatment. The p-AMPK level, which is a sensor for the energy state in various cell types, was also found to be increased after treatment with EF in both male and female rats. Aortic flow, maximum first derivative of developed pressure, left ventricular developed pressure, and infarct size were observed after ischemia-reperfusion and found to be significantly improved in EF-treated rats compared with control animals. Thus EF demonstrated long-term safety as well as exhibiting significant cardioprotective ability during ischemia and reperfusion injury by increased energy production, improved cardiac function, and reduced infarct size.

preconditioning; phosphorylated adenosine 5'-monophosphate kinase; heat shock proteins; adenosine 5'-triphosphate

This article has been cited by other articles:

				B. Juhasz, M. Thirunavukkarasu, R. Pant, L. Zhan, S. V. Penumathsa, E. R. Secor Jr., S. Srivastava, U. Raychaudhuri, V. P. Menon, H. Otani, et al. Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1365 - H1370. [Abstract] [Full Text] [PDF]